Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2356 to 2370 of 8213 results

  1. TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  2. Cytokine adsorption technologies for treating respiratory failure in people with COVID-19

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  3. Archimedes for biopsy of suspected lung cancer

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  4. Actim Pancreatitis for diagnosing acute pancreatitis

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  5. PCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  6. Spartan RX point-of-care CYP2C19 test

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  7. Healthy.io test for home testing of urine albumin to creatinine ratio

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  8. FebriDx for C-reactive protein and myxovirus resistance protein A testing

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  9. Helge for detecting haemolysis

    Topic prioritisation

    Diagnostics guidance
    Topic prioritisation

  10. NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  11. Pembrolizumab with chemoradiation for untreated high-risk advanced cervical cancer [TSID10690]

    Awaiting development Reference number: GID-TA11073 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Pembrolizumab with chemotherapy for adjuvant treatment of newly diagnosed high-risk endometrial cancer after surgery with curative intent [TSID11808]

    Awaiting development Reference number: GID-TA11200 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Pembrolizumab with enzalutamide and androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer [TSID11810]

    Awaiting development Reference number: GID-TA11202 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Perampanel for adjunctive treatment of partial onset or generalised tonic-clonic seizures in children aged below 12 years with epilepsy [ID1587]

    Awaiting development Reference number: GID-TA10519 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Ranibizumab port delivery system for treating diabetic macular oedema [ID6137]

    Awaiting development Reference number: GID-TA11065 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development